Pfizer is more than doubling the cost of COVID drug Paxlovid to $1,390 per course

Pfizer — the American pharmaceutical company that helped manufacture the COVID-19 vaccine — announced on Wednesday that it is hiking the price of its antiviral drug Paxlovid to $1,390 per course, starting in 2024. In a story first reported by The Wall Street Journal, a company spokesman confirmed that Pfizer plans on more than doubling the $529 that the federal government paid for Paxlovid....

Originally posted on salon.com

Lessons from a Nobel Prize-winning vaccine designer on standing up for one’s principles

The first time I talked to Dr. Katalin Karikó on the phone, it was late 2020. I knew that Karikó had helped create mRNA vaccines — the ones developed by pharmaceutical companies like Pfizer/BioNTech (where Karikó works) to fight the COVID-19 pandemic — and I expected to discuss science.

Instead, I unexpectedly found myself wishing I knew how to speak Hungarian....

Originally posted on salon.com